Cargando…
Promotility Action of the Probiotic Bifidobacterium lactis HN019 Extract Compared with Prucalopride in Isolated Rat Large Intestine
Attention is increasingly being focussed on probiotics as potential agents to restore or improve gastrointestinal (GI) transit. Determining mechanism of action would support robust health claims. The probiotic bacterium Bifidobacterium lactis HN019 reduces transit time, but its mechanisms of action...
Autores principales: | Dalziel, Julie E., Anderson, Rachel C., Peters, Jason S., Lynch, Amy T., Spencer, Nick J., Dekker, James, Roy, Nicole C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266733/ https://www.ncbi.nlm.nih.gov/pubmed/28184185 http://dx.doi.org/10.3389/fnins.2017.00020 |
Ejemplares similares
-
Use of the Probiotic Bifidobacterium animalis subsp. lactis HN019 in Oral Diseases
por: Araujo, Lisa Danielly Curcino, et al.
Publicado: (2022) -
Bifidobacterium animalis subsp. lactis HN019 Effects on Gut Health: A Review
por: Cheng, Jing, et al.
Publicado: (2021) -
The Effect of Delivery Matrix on Bifidobacterium animalis subsp. lactis HN019 Survival through In Vitro Human Digestion
por: Yeung, Nicolas, et al.
Publicado: (2023) -
Effects of oral administration of Bifidobacterium animalis subsp. lactis HN019 on the treatment of plaque-induced generalized gingivitis
por: de Almeida Silva Levi, Yara Loyanne, et al.
Publicado: (2022) -
Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults
por: Waller, Philip A, et al.
Publicado: (2011)